Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591
Phone: (914) 847-7000Website: https://www.regeneron.com/Careers: careers.regeneron.com
Latest news
- Dupixent (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
18 April 2025 - Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
26 February 2025 - Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
11 February 2025 - FDA Revokes EUA for REGEN-COV (casirivimab and imdevimab) for the Treatment of COVID-19
13 December 2024 - Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of Treatment and Additional Types of Lymphoma
9 December 2024 - Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD
27 September 2024 - Dupixent Approved in the US as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps
13 September 2024 - Regeneron Provides Update on Biologics License Application for Linvoseltamab
20 August 2024 - Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
16 June 2024 - Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
7 April 2024
Drugs Associated with Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 9 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Arcalyst
Generic name: rilonacept Drug class: interleukin inhibitors |
5 reviews | 10 / 10 |
|
Dupixent
Generic name: dupilumab Drug class: interleukin inhibitors |
455 reviews | 7.2 / 10 |
|
Evkeeza
Generic name: evinacumab Drug class: miscellaneous antihyperlipidemic agents |
||
|
Eylea
Generic name: aflibercept Drug class: anti-angiogenic ophthalmic agents |
65 reviews | 7.2 / 10 |
|
Eylea HD
Generic name: aflibercept Drug class: anti-angiogenic ophthalmic agents |
3 reviews | 8.7 / 10 |
|
Kevzara
Generic name: sarilumab Drug class: antirheumatics, interleukin inhibitors |
25 reviews | 6.7 / 10 |
|
Libtayo
Generic name: cemiplimab Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors) |
8 reviews | 8.8 / 10 |
|
Praluent
Generic name: alirocumab Drug class: PCSK9 inhibitors |
272 reviews | 6.4 / 10 |
|
Veopoz
Generic name: pozelimab Drug class: selective immunosuppressants |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||